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Drugs that produce covalent interstrand cross-links (ICLs) in DNA remain central to the treatment of
cancer, but the cell cycle checkpoints activated by ICLs have received little attention. We have used the fission
yeast, Schizosaccharomyces pombe, to elucidate the checkpoint responses to the ICL-inducing anticancer drugs
nitrogen mustard and mitomycin C. First we confirmed that the repair pathways acting on ICLs in this yeast
are similar to those in the main organisms studied to date (Escherichia coli, budding yeast, and mammalian
cells), principally nucleotide excision repair and homologous recombination. We also identified and disrupted
the S. pombe homologue of the Saccharomyces cerevisiae SNM1/PSO2 ICL repair gene and found that this
activity is required for normal resistance to cross-linking agents, but not other forms of DNA damage. Survival
and biochemical analysis indicated a key role for the “checkpoint Rad” family acting through the chk1-
dependent DNA damage checkpoint in the ICL response. Rhp9-dependent phosphorylation of Chk1 correlates
with G2 arrest following ICL induction. In cells able to bypass the G2 block, a second-cycle (S-phase) arrest was
observed. Only a transient activation of the Cds1 DNA replication checkpoint factor occurs following ICL
formation in wild-type cells, but this is increased and persists in G2 arrest-deficient mutants. This likely
reflects the fraction of cells escaping the G2 damage checkpoint and arresting in the subsequent S phase due
to ICL replication blocks. Disruption of cds1 confers increased resistance to ICLs, suggesting that this
second-cycle S-phase arrest might be a lethal event.
Agents that produce covalent interstrand cross-links (ICLs)
between the complementary strands of the DNA double helix
remain a key component of many cancer chemotherapy regi-
mens (36). Although drugs such as the nitrogen mustards also
produce abundant DNA monoadducts, there is compelling ev-
idence that ICLs are the critical cytotoxic lesion (44) and kill
proliferating cells by disrupting essential processes such as
transcription and replication.
In the best-characterized model organisms, Escherichia coli
and Saccharomyces cerevisiae, the response to ICLs is known to
involve both nucleotide excision repair (NER) and homolo-
gous recombination (13, 24, 35, 39, 54). In these systems ex-
perimental evidence is consistent with two main scenarios for
ICL repair via a combination of these pathways. The bacterial
model invokes an initial ICL “uncoupling” reaction by NER,
incising the ICL on one strand only, followed by a recA-depen-
dent recombination event into the (resected) gap created, pro-
viding a template for the subsequent excision repair of the
opposing adducted strand (13, 58). For S. cerevisiae there is
evidence supporting a related pathway during psoralen ICL
repair but with the key difference that NER may excise the
cross-linked DNA on both strands, producing a double-strand
break (DSB) intermediate, which is then repaired through
homologous recombination (24, 39). In addition, an accumu-
lating body of evidence from studies of yeast and mammalian
cells suggests that events during DNA replication may influ-
ence the processing of nitrogen mustard ICLs (1, 14, 35). In
rapidly dividing (exponential-phase) yeast cells there is a re-
quirement for functional homologous recombination, and
DNA DSBs form at high frequency (35). Interestingly these
DSBs still form in the absence of functional NER and there-
fore could be associated with either of the two recombination
repair pathways proposed above. These DSBs most likely arise
as a result of processing events at replication forks stalled by
ICLs (14, 35).
To date, the cell cycle checkpoints elicited in response to
interstrand cross-linking agents have received little attention
(16). This is clearly of considerable importance since tumors
often exhibit dysregulated checkpoint activity (18), and the
response to cross-linking drugs might be influenced by this.
Here we take advantage of the fission yeast, Schizosaccharo-
myces pombe, as a model organism to define the checkpoints
involved in the ICL response. This yeast has been the subject
of intense investigation, leading to a detailed understanding of
its cell cycle and the checkpoints activated by DNA damage
(10).
At the heart of the checkpoint response in S. pombe are the
checkpoint Rad proteins (Rad1, Rad3, Rad9, Rad17, Rad26,
and Hus1) (3, 4, 19, 26, 49). Rad3 and Rad26 exist as a complex
(17) which signals to downstream effectors in response to DNA
damage through the lipid kinase motif (ATM-related) activity
of Rad3 (33). The Rad1-Rad9-Hus1 proteins form a complex
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that resembles the PCNA sliding clamp that may act to gen-
erate a checkpoint signal at aberrant DNA structures (11).
Rad17 belongs to a further complex which, by analogy with the
S. cerevisiae and human homologues, contains the four small
subunits of the replication factor C and is required for the
association of Rad9-Rad1-Hus1 (9-1-1) complex proteins with
DNA damage (9). The checkpoint Rad family proteins are
required for both the replication checkpoint, which is activated
by replication fork blocks (such as those induced by hydroxy-
urea [HU] treatment) preventing mitosis, and the DNA dam-
age checkpoint, acting to arrest cells in late S or G2 following
ionizing radiation treatment (10, 19, 47). In response to repli-
cation blocks, Rad3 phosphorylates and activates Cds1 (29),
whereas during the damage checkpoint Rad3 phosphorylates
Chk1 (46, 62); however, the biological significance of this latter
event is still not understood. In addition, when Cds1 is absent,
blocking DNA replication activates Chk1. This is interpreted
as follows: normally, Cds1 prevents the occurrence of DNA
damage in S phase when replication forks are stalled, as well as
ensuring that mitosis is inhibited. In the absence of Cds1, the
resulting DNA damage from stalled and/or collapsed replica-
tion activates the Chk1-dependent DNA damage checkpoint to
prevent mitosis (17, 29). The kinases Cds1 and Chk1 prevent
the activation of the Cdc2-Cdc13 complex through mainte-
nance of Cdc2 Tyr15 phosphorylation (45, 48).
Given the complexities of ICL metabolism, we wished to
determine if these adducts elicit replication checkpoints (since
they are potent inhibitors of replication) or DNA damage
checkpoints (since they are highly distorting lesions which are
associated with DSBs) or whether both of these key check-
points are utilized. We first conducted a large-scale sensitivity
screen of mutants in the main DNA damage response path-
ways to gain an overview of the key factors involved. Func-
tional studies confirmed and extended the findings of this
screen, at both a biochemical and a physiological level. Our
experiments demonstrate that the damage checkpoint in G2,
mediated through Chk1, is the primary pathway activated by
ICLs in fission yeast, whereas the replication checkpoint uti-
lizing Cds1 is a less significant, secondary response, which may
actually be detrimental to cell survival.
MATERIALS AND METHODS
S. pombe disruption strategy for PSO2/SNM1. The PSO2/SNM1 gene was
deleted by methods described in reference 6. The KanMX6 module, conferring
G418 resistance, was targeted by homologous integration in the open reading
frame, 72 nucleotides upstream and 15 nucleotides downstream of the open
reading frame, respectively.
Drugs. Analytical-grade mechlorethamine (nitrogen mustard or HN2) and
mitomycin C (MMC) were purchased from Sigma Chemical Co. (Poole, United
Kingdom). Mononitrogen mustard (HN1 or 2-dimethylaminoethylchloride hy-
drochloride), 99% pure, was obtained from Aldrich (Gillingham, United King-
dom).
Sensitivity assays. Liquid yeast extract with supplements (YES) medium was
inoculated with a single colony picked from a freshly streaked (YES) stock plate
and grown overnight at 28°C with vigorous shaking. Cells were counted micro-
scopically, and only cultures with 2  107 cells/ml were used. Cells were
resuspended in phosphate-buffered saline at a density of 2  107 cells/ml, and
2-ml aliquots were treated with the desired concentration of drug (freshly dis-
solved in cold sterile water) for 60 min at 28°C with vigorous shaking. Cells were
harvested, washed twice with 2 ml of phosphate-buffered saline, and then diluted
and plated in duplicate onto YES plates at a density giving rise to 200 colonies
per plate in untreated controls. Plates were incubated for 3 days at 28°C and then
scored. Any experiments giving rise to more than 250 colonies per plate in
untreated controls were rejected. For the serial-dilution colony spotting assay,
cells were serially diluted from 107 to 103 cells/ml and 5 l was spotted onto
plates and irradiated at the indicated doses. For cisplatin, MMC, camptothecin,
and HU experiments, the plates contained the stated concentration of test agent.
Checkpoint analysis. Synchronous cultures of G2 cells were generated on
lactose gradients, as previously described (4), and divided into two samples. One
was treated with drug for 20 min at 30°C, and the other was treated with water.
Cells were washed with water and suspended in complete medium at 30°C.
Samples were taken every 20 min and fixed in methanol. Cells were analyzed by
microscopy after DAPI (4,6-diamidino-2-phenylindole) and Calcofluor staining
as previously described (4).
Phosphorylation-dependent mobility shift of Chk1 kinase and Cds1 kinase
activity. Log-phase cultures were treated with HN2 for 20 min at 30°C, washed
with water, and incubated in complete medium at 30°C. Samples were taken after
1, 2, and 3 h. To analyze Chk1 phosphorylation, protein extracts were obtained
as previously described (11) and were run on 10% acrylamide gels. Triple hem-
agglutinin-tagged (3-HA-tagged) Chk1 protein was detected with HA monoclo-
nal antibody (Roche). The Cds1 kinase activity experiments were performed as
previously described (29).
RESULTS
S. pombe appears to repair ICLs in a manner similar to
those of other eukaryotes. Currently very little is known about
the repair of ICLs in S. pombe. In order for these studies to be
of relevance to other eukaryotic systems, we first screened a
library of S. pombe DNA repair mutants for nitrogen mustard
(HN2) sensitivity to confirm that ICLs are processed in a
similar fashion in this yeast. Disruptants in all the major path-
ways investigated to date in S. cerevisiae and mammalian cells
were available, with the exception of snm1/pso2 mutants. S.
cerevisiae snm1/pso2 mutants were originally isolated on the
basis of their specific sensitivity to the interstrand cross-linking
agents nitrogen mustard and psoralen (23, 50, 51). Conse-
quently we identified a putative S. pombe snm1/pso2 gene and
created a disruptant, as described above (Materials and Meth-
ods). The candidate S. pombe SpSnm1/Pso2 protein has 27 and
37% identity and 42 and 55% similarity with the S. cerevisiae
(ScSnm1) and human Snm1A (HsSnm1) proteins, respectively,
over the entire protein sequence.
Our screen demonstrated that the repair pathways acting on
ICLs in bacteria, S. cerevisiae, and mammals are largely con-
served in S. pombe, and the results are summarized in Fig. 1A.
Compared to the parental, repair-proficient strain (501), a
rad13 mutant (S. cerevisiae Rad2 and mammalian XPG homo-
logue [27], required for the 3 incision during NER) was over
10-fold more sensitive. An rhp18 disruptant (S. cerevisiae and
mammalian Rad18, involved in postreplication repair and
damage tolerance) (60) demonstrated a similar level of sensi-
tivity. The homologous recombination rhp51 and rhp54 mu-
tants (S. cerevisiae and mammalian Rad51 and Rad54) (27)
were also sensitive. All of these observations are consistent
with those previously made for budding yeast (16, 24, 35).
Combining rhp51 with a mutation in top3 (topoisomerase III)
increased the HN2 sensitivity of the rhp51 mutants. Notably,
top3 null mutations on their own are lethal in S. pombe and are
rescued by defects in homologous recombination (43). It there-
fore also appears that the lethal intermediates that accumulate
in rhp51-null cells during ICL processing are less efficiently
resolved in the absence of Top3. The rqh1 family of RecQ
helicases (related to S. cerevisiae SGS1 and the Bloom’s syn-
drome protein) exhibit significant HN2 sensitivity. This has
previously been observed for S. cerevisiae sgs1 mutants (52) and
suggests that this helicase, which is important in maintaining
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replication fork integrity, probably by diverting unrepaired le-
sions into a recombinational bypass pathway (42, 55), also
plays a role in the repair or tolerance of ICLs. The increased
sensitivity of the rqh1 top3 mutant emphasizes the importance
of top3 in the processing of ICLs and suggests that top3 may act
in pathways in addition to Rqh1-dependent recombination
during ICL repair. Other repair mutant strains tested included
a uvde (UV damage endonuclease) disruptant and a rad2-null
strain (S. cerevisiae rad27 and mammalian FEN-1 flap endo-
nuclease) (25, 27, 64), neither of which showed any sensitivity
(data not shown).
The S. pombe pso2/snm1 disruptant demonstrated modest
(around sixfold) sensitivity to HN2 (Fig. 1A). Since the defin-
ing phenotype of S. cerevisiae pso2/snm1 mutants is sensitivity
to cross-linking agents, but not other forms of DNA damage,
we tested the sensitivity of the S. pombe mutant to a range of
genotoxic agents, including gamma radiation, UVC, HU,
camptothecin, cisplatin, and MMC (Fig. 1B). A checkpoint-
defective strain known to be highly sensitive to all of these
agents (the rad3 strain) was included as a positive control in
these experiments. By use of a serial-dilution colony spotting
assay, modest sensitivity was observed in the pso2 strain for the
cross-linking drugs (cisplatin and MMC), but not the other
DNA-damaging agents, indicating that the specific ICL-pro-
cessing activity of Snm1/Pso2 appears conserved between these
two evolutionarily distinct yeasts.
We were concerned that HN2 sensitivity of the repair mu-
tants in Fig. 1 might not specifically be the result of ICL-
processing defects but be due to the abundant monoadducts
produced by this drug (which constitute at least 95% of the
total lesion load). Therefore, we tested key strains for sensi-
tivity to a monofunctional analogue of HN2, termed HN1,
capable of producing only DNA monoadducts (35). None of
the strains analyzed (including rhp54, rhp51, rad13, and pso2
mutants) demonstrated any detectable sensitivity to this agent
at concentrations up to 10 mM—10-fold higher than the high-
est dose of HN2 employed (data not shown).
Nitrogen mustard sensitivity screen of S. pombe cell cycle
checkpoint mutants. A screen of a comprehensive collection of
cell cycle checkpoint mutants was undertaken (Fig. 2). The
checkpoint Rad proteins all demonstrated a significant in-
crease in sensitivity compared to the isogenic parent 501. Cells
disrupted for rad3, rad26, rad1, rad9, rad17, and hus1 were all
sensitive to HN2, confirming that, as for other DNA-damaging
agents such as UV, ionizing radiation, and methyl methane-
sulfonate, this family plays a role in cell cycle integrity in
response to ICLs.
As detailed in the introduction, the downstream effectors
activated by the checkpoint Rad family are defined by two
main pathways, the replication response elicited through Cds1
and the damage response elicited through Chk1 (46). It is
striking (Fig. 2) that cds1 mutants are resistant to HN2, com-
pared to the isogenic parent 501 (cell killing was not observed
at the highest dose used, so therefore they are at least twofold
FIG. 1. (A) Sensitivity of S. pombe DNA repair mutants to nitrogen mustard. Results shown are the doses required to kill 10% of cells and are
the means of two to three independent experiments. The repair-competent wild-type (wt) control was strain 501. (B) Serial-dilution colony spotting
assay for sensitivity to a variety of DNA-damaging agents in wild-type, rad3, and pso2 strains.
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more resistant), whereas chk1-null cells are over 20-fold more
sensitive. A chk1 cds1 double mutant was as sensitive as the
chk1 single mutant, indicating that Cds1 does not play a role in
maintaining viability in the absence of a functional DNA dam-
age checkpoint. In addition, analysis of the rad26.T12 mutant
indicated that this strain behaves indistinguishably from a cds1-
null mutant. The rad26.T12 allele is specifically defective in the
Cds1-dependent replication checkpoint, not the DNA damage
checkpoint mediated by Chk1 (17). This result strongly sup-
ports the observation that defects in the replication checkpoint
pathway confer resistance to HN2. A chk1-HA strain (where
the chk gene bears a 3 HA tag) exhibited near-wild-type sen-
sitivity, which is significant for experimental results presented
below in this report.
Other components of the checkpoint response considered
included Rhp9, Mrc1, and Rad18. Mrc1 is required for the full
activation of Cds1 in response to HU-induced replication
stress (2, 57). However, mrc1 mutant cells were sensitive to
HN2, in contrast to the resistant phenotype of the cds1-null
cells, indicating that Mrc1 might play a role outside the repli-
cation checkpoint during the ICL response. The rhp9 mutant
cells were also sensitive to HN2. This is consistent with the
sensitivity of the chk1 mutant cells, since Rhp9 appears to be
involved in the damage checkpoint, but not the replication
checkpoint (63). Strikingly, a rad18-74 mutant (which is the
most DNA damage sensitive of the rad18 alleles identified
[59]—rad18-null mutants are inviable) was the most sensitive
single mutant strain that we examined in this study. Rad18 is an
SMC (structural maintenance of chromosomes) protein re-
quired to maintain cell cycle arrest in response to both UV and
ionizing radiation damage (28, 59). This protein is also re-
quired for the recombinational repair of ionizing-radiation-
induced DSBs (59). Hence, it is likely that the extreme sensi-
tivity of this strain results from compound defects in both the
repair of ICL-induced DSBs and the Chk1-mediated DNA
damage checkpoint.
We also tested key checkpoint-defective strains for sensitiv-
ity to a monofunctional analogue of HN2 (HN1). None of the
strains analyzed (including rad3, chk1, cds1, and rhp9 mutants)
demonstrated any detectable sensitivity to this agent at con-
centrations up to 10 mM (data not shown). This confirms that
the checkpoint sensitivity profiles observed specifically arise
from defects in the ICL response.
HN2 treatment induces a G2 checkpoint. To establish if
HN2 induces DNA structure-dependent checkpoint activation,
as suggested by the sensitivity of checkpoint mutants, synchro-
nous G2 cultures of cells were tested for mitotic arrest in
response to treatment with HN2. In the wild-type cells (501), 1
mM HN2 treatment induced a G2 checkpoint, in a manner
dependent on the rad3 checkpoint gene (Fig. 3A, top panel).
The checkpoint rad pathway is separated into two subpath-
ways: the DNA damage checkpoint, mediated by the Chk1
kinase, and the DNA replication checkpoint, mediated by the
Cds1 kinase (46). The HN2-induced G2 checkpoint is indepen-
dent of Cds1 and Mrc1, since cds1- and mrc1-null mutants
show a normal mitotic arrest after HN2 treatment compared to
the wild type (Fig. 3A, second panel from top). This observa-
tion is consistent with the absence of HN2 sensitivity in the
cds1-null mutant. However, mrc1 is required for HN2 resis-
tance. This suggests a role for Mrc1 in DNA cross-link repair,
separate from its checkpoint functions, which are mediated
through Cds1 (2, 57). In contrast, the HN2-induced G2 check-
point is dependent on Chk1 and Rhp9, as mutants with null
mutations in both genes fail to delay mitotic progression after
HN2 treatment (Fig. 3A, third panel from top). This is in
agreement with the HN2 sensitivity observed for both mutants.
Finally, the G2 checkpoint induced by HN2 occurs normally in
the rqh1-null mutant (Fig. 3A, bottom panel).
We also monitored the progress of treated cells into the
second cell cycle in the presence of HN2 and observed that
HN2 induced a “second-cycle” delay in the absence of a func-
tional G2 checkpoint. As shown in Fig. 3B, the second mitosis
is delayed in chk1- and rhp9-null mutants compared to that in
the wild-type strain (501) following HN2 treatment (Fig. 3B,
top and middle panels). The second mitosis occurs at approx-
imately 200 min in untreated cells. In wild-type cells (strain
501) treated with HN2, the first cycle is delayed until 400 min
after treatment, and then the second cycle follows without a
significant delay approximately 3 h later. However, in chk1-
FIG. 2. Sensitivity of S. pombe mutants involved in cell cycle pro-
gression and checkpoints to nitrogen mustard. Results shown are the
doses required to kill 10% of cells and are the means of two to three
independent experiments. The repair-competent wild-type control
(strain 501) is designated wt.
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and rhp9-null mutants, where there is no first-cycle delay, the
second cycle is delayed until 400 to 500 min, suggesting that
cells proceed into S phase in the presence of DNA damage.
This causes a block to DNA replication and subsequent acti-
vation of the DNA replication checkpoint. The replication
checkpoint has previously been shown to be dependent on
Cds1 and Rad3 but independent of Chk1 and Rhp9. Consistent
with this, the HN2-induced second-cycle delay is dependent on
Rad3 and Cds1, since it is abolished in a rad3 disruptant strain
and a cds1 chk1 double disruptant (Fig. 3B, bottom panels).
We also tested the monofunctional counterpart of HN2,
HN1, for checkpoint activation (Fig. 4). Consistent with the
lack of sensitivity in checkpoint-deficient strains, this agent
failed to elicit a G2 checkpoint or second-cycle arrest in cells
treated with up to 10 mM HN1 in either a wild-type or a rad3
strain.
HN2 treatment activates Chk1 and Cds1. Chk1 has been
shown to be phosphorylated in response to DNA damage, and
this phosphorylation event generally correlates with its activa-
tion (62). To confirm that HN2 induces a Chk1-dependent G2
checkpoint, we compared Chk1 phosphorylation in asynchro-
nous cultures, following treatment with 1 mM HN2, and in
wild-type and mutant strains carrying the chk1 gene tagged
with 3-HA epitopes (Fig. 5A). Chk1 is rapidly phosphorylated
in response to HN2. Consistent with our analysis above and
with the present literature, this Chk1 phosphorylation does not
occur in the absence of Rhp9. Note, however, that the chk1
disruptants are more sensitive to HN2 than are rhp9 cells (Fig.
2), suggesting that some rhp9-independent activation of Chk1
might occur in response to ICLs. In contrast, and as expected
from the literature, Cds1 and Mrc1 are not required for Chk1
phosphorylation (2, 8). This was important to determine, since
sensitivities of mrc1 and cds1 mutants are not identical.
The activation of the Cds1 kinase has been previously char-
acterized, and it is known that this occurs only in S-phase cells
when DNA is damaged or replication is arrested (29). We
analyzed Cds1 activity following HN2 treatment to ascertain if
HN2 could induce Cds1 kinase. Asynchronous cultures were
treated with 1 mM HN2, and Cds1 was subsequently immuno-
precipitated and assayed for kinase activity against myelin ba-
FIG. 3. Checkpoint analysis in response to HN2 in different null mutants. Synchronous cultures of G2 cells were generated on lactose gradients
and divided into two samples, one of which was treated with HN2 at 1 mM for 20 min. Septation index and DAPI staining were used to monitor
progress through the cell cycle. (A) HN2 treatment induces mitotic arrest, and this arrest is dependent on Rad3 (top panel) and Chk1 and Rhp9
(third panel from top). In contrast the mitotic delay induced by HN2 is independent of Cds1 and Mrc1 (second panel from top) and Rqh1 (bottom
panel). (B) HN2 induces a second-cell-cycle delay in the absence of a functional G2 DNA damage checkpoint. The second cell cycle is delayed in
chk1- and rhp9-null mutants (middle panels) compared to the wild-type strain (top panel). The Rad3 checkpoint protein and Cds1 are required
for the second-cell-cycle delay induced by HN2 (bottom panels). Wt, wild type.
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sic protein (Fig. 5B). A positive control of cells treated with 20
mM HU, a known activator of Cds1 during S phase, was also
included. In the wild-type strain (501), Cds1 is transiently ac-
tivated: kinase activity is increased approximately sevenfold
within 1 h of HN2 exposure and subsequently declines (four-
fold at 2 h following HN2 treatment). The kinase activity as-
sayed following HN2 treatment is dependent on Cds1, as no
kinase activity is detected in the absence of Cds1 (Fig. 5B).
Mrc1 is essential for the activation of Cds1 in response to HU
(2, 57). In agreement with this, no Cds1 induction is detected
in mrc1 mutant cells (Fig. 5B). In contrast, Chk1 and Rhp9 are
not required for Cds1 activation. Moreover, in chk1-d and
rhp9-d mutants, 2 h following HN2 exposure, the Cds1 kinase
activity remains high and does not decline at 2 h. The most
probable explanation for this is the absence of HN2-induced
G2 checkpoint in chk1- and rhp9-null mutants: cells progress
directly into S phase with DNA damage, which leads to Cds1
and replication checkpoint activation. In the wild-type strain,
the HN2-induced G2 checkpoint arrests the majority of cells in
G2, preventing cells not in S phase at the time of treatment
from progressing into S phase and activating Cds1. The fact
that cells arrested in G2 then enter the next cycle without
activating the Cds1 checkpoint clearly indicates that repair is
occurring in the G2 period.
MMC induces the same checkpoint response as does HN2.
Since it is possible that the responses reported up to this point
are agent specific to HN2, we repeated several key experiments
with MMC as the cross-linking agent. The sensitivity profile of
key repair and checkpoint mutants is the same as that observed
for HN2 (Fig. 6A). The recombination rhp1 mutant, the NER
mutant rad13 strain, and the RecQ helicase (rqh1) disruptant
are all significantly MMC sensitive. Of the key checkpoint
mutants screened, the rad3, chk1-d, and cds1-d chk1-d strains
were all sensitive, whereas the cds1-d strain was somewhat
more resistant than the wild type (strain 501). As for HN2, a
FIG. 4. Checkpoint analysis in response to HN1 in different null
mutants. Synchronous cultures of G2 cells were generated on lactose
gradients and divided into two samples, one of which was treated with
HN1 at 1 (filled circles), 2 (filled triangles), or 10 (filled squares) mM
for 20 min. Septation index and DAPI staining were used to monitor
progress through the cell cycle. HN1 fails to induce G2 arrest in a
wild-type (Wt) strain (501). In addition, no second-cycle arrest is seen
in either the wild type (501) or the rad3-d mutant.
FIG. 5. Chk1 phosphorylation and Cds1 activation in response to HN2. (A) The phosphorylation-dependent mobility shift of Chk1 kinase was
assayed with different null mutants. All the strains contain a Chk1 gene tagged with 3-HA epitopes. Samples from asynchronous cultures treated
with 1 mM HN2 were taken at the time indicated. Chk1 was detected with anti-HA monoclonal antibody, and arrows indicate the phosphorylation
shift. HN2 induced Chk1 phosphorylation in an Rhp9-dependent but Cds1- and Mrc1-independent manner. (B) HN2 induced kinase activity in
different null mutants. Samples from asynchronous cultures were taken 1 and 2 h after treatment with 1 mM HN2. Samples from asynchronous
cultures treated for 1 h with 20 mM HU were used as control for the Cds1 kinase activation. The Cds1 kinase activity was detected as previously
described (27). The upper panel corresponds to Cds1 protein level detection by immunoblotting, after immunoprecipitation. The lower panel
corresponds to the Cds1 kinase activity assayed on the myelin basic protein substrate (MBP). The bar graph displays the Cds1 kinase activity
quantified by PhosphorImager analysis, corrected for the Cds1 protein levels detected after immunoprecipitation. Wt, wild type.
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strong G2 checkpoint was elicited in response to MMC, and
this was Rad3 dependent (Fig. 6B).
DISCUSSION
Before embarking upon a detailed analysis of cell cycle
checkpoints involved in the S. pombe ICL response, it was
important to confirm that this organism repairs ICLs by mech-
anisms similar to those of the eukaryotic systems studied to
date (principally S. cerevisiae, and to some extent mammalian
cells, in particular Chinese hamster ovary cells). The sensitivity
data (Fig. 1) obtained with a panel of S. pombe DNA repair
mutants indicated that this is indeed the case. Both NER
(Rad13) and homologous recombination (Rhp51) are impor-
tant determinants of sensitivity, as is the postreplication repair
pathway governed by Rhp18. These findings are consistent
with several studies of budding yeast which suggest a key role
for NER in the initial incision at ICLs (24, 34) and a subse-
quent role for homologous recombination in providing the
genetic information to complete repair through a recombina-
tion reaction, probably initiated by DSBs (16, 24, 35).
As stated above, recombinational processing of ICLs in-
volves the formation of DSB intermediates that are mainly
repaired by Rad52-controlled events in budding yeast, with a
minor role for nonhomologous end joining (NHEJ). In con-
trast to the repair of DSBs induced by ionizing radiation, there
is also a requirement for the Pso2/Snm1 protein at a postinci-
sion (NER) stage of ICL repair (31). S. cerevisiae cells carrying
a mutated pso2/snm1 allele are specifically sensitive to ICL-
inducing agents but show wild-type resistance to monofunc-
tional alkylating drugs and ionizing radiation (12, 50). In this
study, we have identified the S. pombe homologue of Pso2/
Snm1 and created a deletion mutant. The observation that S.
pombe snm1/pso2 mutants are also modestly sensitive to a
variety of cross-linking agents indicates that the function of the
Snm1/Pso2 protein in DNA metabolism is at least partly con-
served between these two evolutionarily distinct yeasts. This is
FIG. 6. (A) Serial-dilution colony spotting assay for sensitivity to MMC in representative checkpoint (upper panels) and repair (lower panels)
mutants. (B) MMC treatment induces mitotic arrest, and this arrest is dependent on Rad3. Experiments were performed as described for Fig. 3.
Results for two drug concentrations, 1 and 3 mM, are shown. Wt, wild type.
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an important observation, as mouse embryonic stem cells dis-
rupted for the paralog SNM1 demonstrate sensitivity solely to
MMC (of the cross-linking agents tested), possibly due to func-
tional redundancy with other murine homologues (15). The
Pso2/Snm1 protein is a member of the metallo--lactamase
family of enzymes that share a hydrolytic domain similar to
that of the mRNA cleavage and polyadenylation specificity
factor, CPSA (5). A human gene clearly related to Pso2/Snm1,
Artemis, has been identified as the mutant gene in radiation-
sensitive severe combined immune deficiency (40), where the
phenotype results from defects in V(D)J recombination and in
the NHEJ of DSBs (30). This has been shown to arise from the
failure of hairpin opening during V(D)J processing and defec-
tive processing of DNA ends during NHEJ. Artemis is a single-
strand-specific 5-to-3 exonuclease which, when complexed
with DNA-dependent protein kinase, is phosphorylated by the
latter, acquiring 5- and 3-overhang and hairpin endonuclease
activity (30). The use of model organisms such as S. cerevisiae
and S. pombe, for which detailed genetic studies are possible,
will be a powerful tool in further elucidating the role of the
PSO2/SNM1 family in DNA repair.
Cross-links activate the DNA damage checkpoint mediated
by Chk1 and Rhp9. Cell cycle arrest is a part of the cellular
response to DNA damage and is thought to ensure correct
chromosome segregation in mitosis and prevent chromosome
instability. Many ICL-inducing agents are used in the treat-
ment of cancers, but little is known about the effects of ICLs on
cell cycle delays. Here, we analyzed cell cycle arrest in response
to ICLs. Our experiments lead us to conclude that the G2 DNA
damage checkpoint mediated by Chk1 (3, 61) and Rhp9 (63) is
the most biologically significant checkpoint pathway activated
in response to HN2. The Cds1 (29, 41)- and Mrc1 (2, 57)-
dependent DNA replication checkpoint pathway is also acti-
vated transiently, but its loss has little biological consequence
in our assays. Several lines of evidence lead us to this conclu-
sion. First, the chk1- and rhp9-null mutants are HN2 and MMC
sensitive, which is not the case for the cds1-null mutant. Sec-
ond, Chk1 is clearly rapidly phosphorylated in response to
HN2 in a Rhp9-dependent and Cds1-Mrc1-independent man-
ner. Third, the HN2-induced G2 checkpoint does not occur in
the absence of chk1 or rhp9. Finally, Cds1 kinase activity is only
transiently activated in response to HN2, suggesting that HN2
does not lead to prolonged cell accumulation within S phase.
Consistent with our genetic and biochemical observations,
ICLs induced by cisplatin or psoralen have been shown else-
where to induce cell cycle arrest in S. cerevisiae G2/M but not
to induce an S-phase delay (except in response to high levels of
ICLs) (21, 22, 38). Together, these results suggest that repli-
cation can tolerate or bypass a certain number of ICLs.
Cells disrupted for rad3, rad26, rad1, rad9, rad17, and hus1
are all sensitive to HN2. Since we observe no cross-link-in-
duced cell cycle arrest (HN2 or MMC) in the absence of rad3,
it is likely that the arrest induced by cross-links is dependent on
all checkpoint rad (10) gene products. The G2 arrest presum-
ably represents a checkpoint that allows time for ICL repair by
a combination of NER and homologous recombination. In the
absence of this checkpoint, cells will initiate replication with
unrepaired DNA damage, leading to DNA replication check-
point activation mediated by Cds1 (8). This can be seen in the
extended second-cycle delay observed in the absence of Chk1
and Rhp9 (Fig. 3B) and in the potentiation of the induction of
Cds1 kinase activity observed in chk1- and rhp9-null mutants
(Fig. 5). As the chk1 and rhp9 mutants show HN2 sensitivity
compared to the wild-type and cds1-d strains, it could be spec-
ulated that ICLs are more toxic or less efficiently repaired
during or after replication. In fact, as cds1-d mutants are ac-
tually more resistant to HN2 and MMC, it is possible that
delaying S phase and attempting to repair ICLs in S phase are
positively detrimental to cell survival.
Model for S. pombe checkpoint response to ICLs and rele-
vance to cancer. Taken together, the findings of this study
allow us to suggest a basic model of the S. pombe response to
ICLs (Fig. 7). In a growing population of cells, which are
primarily in the G2 phase of the cell cycle, the presence of ICLs
triggers the DNA damage checkpoint, requiring the full family
of checkpoint Rad factors, leading to Rad3-dependent phos-
phorylation and activation of Chk1. The resulting arrest per-
mits time for ICL repair through the combined action of NER
and homologous recombination (24, 35). Following the com-
pletion of repair, cells reenter the normal cell cycle and pass
through mitosis. In the absence of an operative damage check-
point, cells progress through to the following S phase, where
the ICLs are detected, presumably as a replication fork block.
FIG. 7. Model for the ICL checkpoint response in S. pombe. HR,
homologous recombination.
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This triggers the Cds1-dependent replication checkpoint. The
marked resistance of cds1-null cells to cross-linking agents
suggests that this event is deleterious and might represent a
terminal arrest event in at least a subset of cells.
The role of Chk1 as the major mediator of the ICL check-
point arrest has relevance to cancer biology, as mammalian
homologues of this gene are known. Mouse embryonic stem
cells disrupted for CHK1 are defective in the regulation of the
G2/M DNA damage checkpoint (53, 56), and mammalian
Chk1 appears to exert its major regulatory effect through the
phosphorylation and inactivation of cyclin-dependent kinase
following DNA damage (20, 32). Extrapolation of the results
presented in our present study suggests that mammalian cells
overexpressing Chk1 might be resistant to ICL-inducing
agents, whereas cancers suffering dysregulation of this check-
point might be more sensitive to these drugs. In addition, the
fact that the absence of Cds1 confers resistance to HN2 in S.
pombe could have some implications in chemotherapy, since
some tumors harbor mutations of CHK2, the CDS1 homologue
in mammalian cells. Indeed, heterozygous germ line mutations
in chk2 have been identified in some patients with Li-Fraumeni
syndrome, a familial cancer phenotype (7). A chk2 mutation
(1100delc) leading to a truncating variant that abolishes the
kinase activity results in a 2-fold increase of breast cancer risk
in women and a 10-fold increase of risk in men (37). In this
context, the use of ICL-inducing agents in treatment of tumors
defective for CHK2 may have a reduced therapeutic index.
While the yeast checkpoints represent a simple view of events
in higher organisms, our study points to a potential pivotal role
for Chk1 and Cds1-Chk2 in the response to cross-linking an-
ticancer agents.
ACKNOWLEDGMENTS
We thank J. Murray for kindly sharing unpublished strains.
This work was supported, in part, by EC grant FIGH-CT-1999-0010
(to A.M.C.) and was also partly supported by Cancer Research UK
Programme grant SP2000/0402 (to J.A.H.). L.J.B. was supported by a
Cancer Research UK studentship, and P.J.M. was supported by a
Royal Society University Research fellowship.
REFERENCES
1. Akkari, Y. M., R. L. Bateman, C. A. Reifsteck, S. B. Olson, and M. Grompe.
2000. DNA replication is required to elicit cellular responses to psoralen-
induced DNA interstrand cross-links. Mol. Cell. Biol. 20:8283–8289.
2. Alcasabas, A. A., A. J. Osborn, J. Bachant, F. Hu, P. J. Werler, K. Bousset,
K. Furuya, J. F. Diffley, A. M. Carr, and S. J. Elledge. 2001. Mrc1 transduces
signals of DNA replication stress to activate Rad53. Nat. Cell Biol. 3:958–
965.
3. al-Khodairy, F., and A. M. Carr. 1992. DNA repair mutants defining G2
checkpoint pathways in Schizosaccharomyces pombe. EMBO J. 11:1343–
1350.
4. al-Khodairy, F., E. Fotou, K. S. Sheldrick, D. J. Griffiths, A. R. Lehmann,
and A. M. Carr. 1994. Identification and characterization of new elements
involved in checkpoint and feedback controls in fission yeast. Mol. Biol. Cell
5:147–160.
5. Aravind, L., D. R. Walker, and E. V. Koonin. 1999. Conserved domains in
DNA repair proteins and evolution of repair systems. Nucleic Acids Res.
27:1223–1242.
6. Bahler, J., J. Q. Wu, M. S. Longtine, N. G. Shah, A. McKenzie III, A. B.
Steever, A. Wach, P. Philippsen, and J. R. Pringle. 1998. Heterologous
modules for efficient and versatile PCR-based gene targeting in Schizosac-
charomyces pombe. Yeast 14:943–951.
7. Bell, D. W., J. M. Varley, T. E. Szydlo, D. H. Kang, D. C. Wahrer, K. E.
Shannon, M. Lubratovich, S. J. Verselis, K. J. Isselbacher, J. F. Fraumeni,
J. M. Birch, F. P. Li, J. E. Garber, and D. A. Haber. 1999. Heterozygous
germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286:2528–
2531.
8. Brondello, J. M., M. N. Boddy, B. Furnari, and P. Russell. 1999. Basis for the
checkpoint signal specificity that regulates Chk1 and Cds1 protein kinases.
Mol. Cell. Biol. 19:4262–4269.
9. Caspari, T., and A. M. Carr. 2002. Checkpoints: how to flag up double-
strand breaks. Curr. Biol. 12:R105–R107.
10. Caspari, T., and A. M. Carr. 1999. DNA structure checkpoint pathways in
Schizosaccharomyces pombe. Biochimie 81:173–181.
11. Caspari, T., M. Dahlen, G. Kanter-Smoler, H. D. Lindsay, K. Hofmann, K.
Papadimitriou, P. Sunnerhagen, and A. M. Carr. 2000. Characterization of
Schizosaccharomyces pombe Hus1: a PCNA-related protein that associates
with Rad1 and Rad9. Mol. Cell. Biol. 20:1254–1262.
12. Cassier, C., and E. Moustacchi. 1981. Mutagenesis induced by mono- and
bi-functional alkylating agents in yeast mutants sensitive to photo-addition of
furocoumarins (pso). Mutat. Res. 84:37–47.
13. Cole, R. S., and R. R. Sinden. 1975. Repair of cross-linked DNA in Esche-
richia coli. Basic Life Sci. 5B:487–495.
14. De Silva, I. U., P. J. McHugh, P. H. Clingen, and J. A. Hartley. 2000.
Defining the roles of nucleotide excision repair and recombination in the
repair of DNA interstrand cross-links in mammalian cells. Mol. Cell. Biol.
20:7980–7990.
15. Dronkert, M. L., J. de Wit, M. Boeve, M. L. Vasconcelos, H. van Steeg, T. L.
Tan, J. H. Hoeijmakers, and R. Kanaar. 2000. Disruption of mouse SNM1
causes increased sensitivity to the DNA interstrand cross-linking agent mi-
tomycin C. Mol. Cell. Biol. 20:4553–4561.
16. Dronkert, M. L., and R. Kanaar. 2001. Repair of DNA interstrand cross-
links. Mutat. Res. 486:217–247.
17. Edwards, R. J., N. J. Bentley, and A. M. Carr. 1999. A Rad3-Rad26 complex
responds to DNA damage independently of other checkpoint proteins. Nat.
Cell Biol. 1:393–398.
18. Elledge, S. J. 1996. Cell cycle checkpoints: preventing an identity crisis.
Science 274:1664–1672.
19. Enoch, T., A. M. Carr, and P. Nurse. 1992. Fission yeast genes involved in
coupling mitosis to completion of DNA replication. Genes Dev. 6:2035–
2046.
20. Graves, P. R., L. Yu, J. K. Schwarz, J. Gales, E. A. Sausville, P. M.
O’Connor, and H. Piwnica-Worms. 2000. The Chk1 protein kinase and the
Cdc25C regulatory pathways are targets of the anticancer agent UCN-01.
J. Biol. Chem. 275:5600–5605.
21. Grossmann, K. F., J. C. Brown, and R. E. Moses. 1999. Cisplatin DNA
cross-links do not inhibit S-phase and cause only a G2/M arrest in Saccha-
romyces cerevisiae. Mutat. Res. 434:29–39.
22. Grossmann, K. F., A. M. Ward, and R. E. Moses. 2000. Saccharomyces
cerevisiae lacking Snm1, Rev3 or Rad51 have a normal S-phase but arrest
permanently in G2 after cisplatin treatment. Mutat. Res. 461:1–13.
23. Henriques, J. A., and E. Moustacchi. 1980. Isolation and characterization of
pso mutants sensitive to photo-addition of psoralen derivatives in Saccharo-
myces cerevisiae. Genetics 95:273–288.
24. Jachymczyk, W. J., R. C. von Borstel, M. R. Mowat, and P. J. Hastings. 1981.
Repair of interstrand cross-links in DNA of Saccharomyces cerevisiae re-
quires two systems for DNA repair: the RAD3 system and the RAD51
system. Mol. Gen. Genet. 182:196–205.
25. Kaur, B., A. M. Avery, and P. W. Doetsch. 1998. Expression, purification, and
characterization of ultraviolet DNA endonuclease from Schizosaccharomyces
pombe. Biochemistry 37:11599–11604.
26. Kostrub, C. F., K. Knudsen, S. Subramani, and T. Enoch. 1998. Hus1p, a
conserved fission yeast checkpoint protein, interacts with Rad1p and is phos-
phorylated in response to DNA damage. EMBO J. 17:2055–2066.
27. Lehmann, A. R. 1996. Molecular biology of DNA repair in the fission yeast
Schizosaccharomyces pombe. Mutat. Res. 363:147–161.
28. Lehmann, A. R., M. Walicka, D. J. Griffiths, J. M. Murray, F. Z. Watts, S.
McCready, and A. M. Carr. 1995. The rad18 gene of Schizosaccharomyces
pombe defines a new subgroup of the SMC superfamily involved in DNA
repair. Mol. Cell. Biol. 15:7067–7080.
29. Lindsay, H. D., D. J. Griffiths, R. J. Edwards, P. U. Christensen, J. M.
Murray, F. Osman, N. Walworth, and A. M. Carr. 1998. S-phase-specific
activation of Cds1 kinase defines a subpathway of the checkpoint response in
Schizosaccharomyces pombe. Genes Dev. 12:382–395.
30. Ma, Y., U. Pannicke, K. Schwarz, and M. R. Lieber. 2002. Hairpin opening
and overhang processing by an Artemis/DNA-dependent protein kinase
complex in nonhomologous end joining and V(D)J recombination. Cell
108:781–794.
31. Magana-Schwencke, N., J. A. Henriques, R. Chanet, and E. Moustacchi.
1982. The fate of 8-methoxypsoralen photoinduced crosslinks in nuclear and
mitochondrial yeast DNA: comparison of wild-type and repair-deficient
strains. Proc. Natl. Acad. Sci. USA 79:1722–1726.
32. Mailand, N., J. Falck, C. Lukas, R. G. Syljuasen, M. Welcker, J. Bartek, and
J. Lukas. 2000. Rapid destruction of human Cdc25A in response to DNA
damage. Science 288:1425–1429.
33. Martinho, R. G., H. D. Lindsay, G. Flaggs, A. J. DeMaggio, M. F. Hoekstra,
A. M. Carr, and N. J. Bentley. 1998. Analysis of Rad3 and Chk1 protein
kinases defines different checkpoint responses. EMBO J. 17:7239–7249.
34. McHugh, P. J., R. D. Gill, R. Waters, and J. A. Hartley. 1999. Excision repair
4736 LAMBERT ET AL. MOL. CELL. BIOL.
 o
n
 June 19, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
of nitrogen mustard-DNA adducts in Saccharomyces cerevisiae. Nucleic Ac-
ids Res. 27:3259–3266.
35. McHugh, P. J., W. R. Sones, and J. A. Hartley. 2000. Repair of intermediate
structures produced at DNA interstrand cross-links in Saccharomyces cerevi-
siae. Mol. Cell. Biol. 20:3425–3433.
36. McHugh, P. J., V. J. Spanswick, and J. A. Hartley. 2001. Repair of DNA
interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet
Oncol. 2:483–490.
37. Meijers-Heijboer, H., A. van den Ouweland, J. Klijn, M. Wasielewski, A. de
Snoo, R. Oldenburg, A. Hollestelle, M. Houben, E. Crepin, M. van Veghel-
Plandsoen, F. Elstrodt, C. van Duijn, C. Bartels, C. Meijers, M. Schutte, L.
McGuffog, D. Thompson, D. Easton, N. Sodha, S. Seal, R. Barfoot, J. Man-
gion, J. Chang-Claude, D. Eccles, R. Eeles, D. G. Evans, R. Houlston, V.
Murday, S. Narod, T. Peretz, J. Peto, C. Phelan, H. X. Zhang, C. Szabo, P.
Devilee, D. Goldgar, P. A. Futreal, K. L. Nathanson, B. Weber, N. Rahman,
and M. R. Stratton. 2002. Low-penetrance susceptibility to breast cancer due
to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat.
Genet. 31:55–59.
38. Meniel, V., N. Magana-Schwencke, D. Averbeck, and R. Waters. 1997. Pref-
erential incision of interstrand crosslinks induced by 8-methoxypsoralen plus
UVA in yeast during the cell cycle. Mutat. Res. 384:23–32.
39. Miller, R. D., L. Prakash, and S. Prakash. 1982. Genetic control of excision
of Saccharomyces cerevisiae interstrand DNA cross-links induced by psoralen
plus near-UV light. Mol. Cell. Biol. 2:939–948.
40. Moshous, D., I. Callebaut, R. de Chasseval, B. Corneo, M. Cavazzana-Calvo,
F. Le Deist, I. Tezcan, O. Sanal, Y. Bertrand, N. Philippe, A. Fischer, and
J. P. de Villartay. 2001. Artemis, a novel DNA double-strand break repair/
V(D)J recombination protein, is mutated in human severe combined im-
mune deficiency. Cell 105:177–186.
41. Murakami, H., and H. Okayama. 1995. A kinase from fission yeast respon-
sible for blocking mitosis in S phase. Nature 374:817–819.
42. Murray, J. M., H. D. Lindsay, C. A. Munday, and A. M. Carr. 1997. Role of
Schizosaccharomyces pombe RecQ homolog, recombination, and checkpoint
genes in UV damage tolerance. Mol. Cell. Biol. 17:6868–6875.
43. Oakley, T. J., A. Goodwin, R. K. Chakraverty, and I. D. Hickson. 2002.
Inactivation of homologous recombination suppresses defects in topoisom-
erase III-deficient mutants. DNA Repair (Amsterdam) 1:463–482.
44. O’Connor, P. M., and K. W. Kohn. 1990. Comparative pharmacokinetics of
DNA lesion formation and removal following treatment of L1210 cells with
nitrogen mustards. Cancer Commun. 2:387–394.
45. Rhind, N., B. Furnari, and P. Russell. 1997. Cdc2 tyrosine phosphorylation
is required for the DNA damage checkpoint in fission yeast. Genes Dev.
11:504–511.
46. Rhind, N., and P. Russell. 2000. Chk1 and Cds1: linchpins of the DNA
damage and replication checkpoint pathways. J. Cell Sci. 113:3889–3896.
47. Rhind, N., and P. Russell. 1998. Mitotic DNA damage and replication
checkpoints in yeast. Curr. Opin. Cell Biol. 10:749–758.
48. Rhind, N., and P. Russell. 1998. Tyrosine phosphorylation of Cdc2 is re-
quired for the replication checkpoint in Schizosaccharomyces pombe. Mol.
Cell. Biol. 18:3782–3787.
49. Rowley, R., S. Subramani, and P. G. Young. 1992. Checkpoint controls in
Schizosaccharomyces pombe: rad1. EMBO J. 11:1335–1342.
50. Ruhland, A., E. Haase, W. Siede, and M. Brendel. 1981. Isolation of yeast
mutants sensitive to the bifunctional alkylating agent nitrogen mustard. Mol.
Gen. Genet. 181:346–351.
51. Ruhland, A., M. Kircher, F. Wilborn, and M. Brendel. 1981. A yeast mutant
specifically sensitive to bifunctional alkylation. Mutat. Res. 91:457–462.
52. Saffi, J., V. R. Pereira, and J. A. Henriques. 2000. Importance of the Sgs1
helicase activity in DNA repair of Saccharomyces cerevisiae. Curr. Genet.
37:75–78.
53. Sanchez, Y., C. Wong, R. S. Thoma, R. Richman, Z. Wu, H. Piwnica-Worms,
and S. J. Elledge. 1997. Conservation of the Chk1 checkpoint pathway in
mammals: linkage of DNA damage to Cdk regulation through Cdc25. Sci-
ence 277:1497–1501.
54. Sladek, F. M., M. M. Munn, W. D. Rupp, and P. Howard-Flanders. 1989. In
vitro repair of psoralen-DNA cross-links by RecA, UvrABC, and the 5-
exonuclease of DNA polymerase I. J. Biol. Chem. 264:6755–6765.
55. Stewart, E., C. R. Chapman, F. Al-Khodairy, A. M. Carr, and T. Enoch. 1997.
rqh1, a fission yeast gene related to the Bloom’s and Werner’s syndrome
genes, is required for reversible S phase arrest. EMBO J. 16:2682–2692.
56. Takai, H., K. Tominaga, N. Motoyama, Y. A. Minamishima, H. Nagahama,
T. Tsukiyama, K. Ikeda, K. Nakayama, and M. Nakanishi. 2000. Aberrant
cell cycle checkpoint function and early embryonic death in Chk1(/)
mice. Genes Dev. 14:1439–1447.
57. Tanaka, K., and P. Russell. 2001. Mrc1 channels the DNA replication arrest
signal to checkpoint kinase Cds1. Nat. Cell Biol. 3:966–972.
58. Van Houten, B., H. Gamper, S. R. Holbrook, J. E. Hearst, and A. Sancar.
1986. Action mechanism of ABC excision nuclease on a DNA substrate
containing a psoralen crosslink at a defined position. Proc. Natl. Acad. Sci.
USA 83:8077–8081.
59. Verkade, H. M., S. J. Bugg, H. D. Lindsay, A. M. Carr, and M. J. O’Connell.
1999. Rad18 is required for DNA repair and checkpoint responses in fission
yeast. Mol. Biol. Cell 10:2905–2918.
60. Verkade, H. M., T. Teli, L. V. Laursen, J. M. Murray, and M. J. O’Connell.
2001. A homologue of the Rad18 postreplication repair gene is required for
DNA damage responses throughout the fission yeast cell cycle. Mol. Genet.
Genomics 265:993–1003.
61. Walworth, N., S. Davey, and D. Beach. 1993. Fission yeast chk1 protein
kinase links the rad checkpoint pathway to cdc2. Nature 363:368–371.
62. Walworth, N. C., and R. Bernards. 1996. rad-dependent response of the
chk1-encoded protein kinase at the DNA damage checkpoint. Science 271:
353–356.
63. Willson, J., S. Wilson, N. Warr, and F. Z. Watts. 1997. Isolation and char-
acterization of the Schizosaccharomyces pombe rhp9 gene: a gene required
for the DNA damage checkpoint but not the replication checkpoint. Nucleic
Acids Res. 25:2138–2146.
64. Yonemasu, R., S. J. McCready, J. M. Murray, F. Osman, M. Takao, K.
Yamamoto, A. R. Lehmann, and A. Yasui. 1997. Characterization of the
alternative excision repair pathway of UV-damaged DNA in Schizosaccha-
romyces pombe. Nucleic Acids Res. 25:1553–1558.
VOL. 23, 2003 DNA CROSS-LINK CHECKPOINTS IN S. POMBE 4737
 o
n
 June 19, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
